Syneos Health, Inc. - (SYNH) News
Filter SYNH News Items
SYNH News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
SYNH News Highlights
- For SYNH, its 30 day story count is now at 6.
- Over the past 21 days, the trend for SYNH's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- AC are the most mentioned tickers in articles about SYNH.
Latest SYNH News From Around the Web
Below are the latest news stories about SYNEOS HEALTH INC that investors may wish to consider to help them evaluate SYNH as an investment opportunity.
Here’s Why ClearBridge Investments Small Cap Strategy Sold Syneos Health (SYNH)ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” second quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed the Russell 2000 Index in the second quarter. On an absolute basis, the strategy gained all 11 sectors it invested in during the quarter. IT and industrial […] |
Syneos Health (SYNH) Declares Strategic Partnership With OracleSyneos Health (SYNH) announces an expanded collaboration with Oracle to accelerate patient recruitment capabilities. |
Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health EquityMORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic collaboration that will expand its relationship with Oracle. Using the Oracle Cerner Learning Health Network (LHN) and elements of Oracle’s suite of study startup solutions, the companies seek to help reduce the time it takes to recruit patients for clinical studies and increase the diversity of patient populations pa |
Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?While Syneos Health, Inc. ( NASDAQ:SYNH ) might not be the most widely known stock at the moment, it maintained its... |
Syneos Health, Inc. and Star Parent, Inc. Announce Proposed $1.70 Billion Offering of Senior Secured NotesMORRISVILLE, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Star Parent, Inc. (the “Issuer” or the “Company”) and Syneos Health, Inc. (“Syneos Health”), announced today that, subject to market conditions and other factors, the Issuer intends to offer $1,700,000,000 aggregate principal amount of Senior Secured Notes due 2030 (the “Notes”). The Issuer intends to use the proceeds from the offering together with other financing sources to fund the previously announced acquisition of Syneos Health (the “Ac |
Syneos Health (SYNH) Expands Catalyst Site Program to ChinaSyneos Health (SYNH) announces a collaboration with China's Wuhan Union Hospital, expanding clinical trial capabilities. |
BB Stock Alert: Is Veritas Capital About to Takeover Blackberry?Blackberry (BB) stock jumped a surprise 18% today on rumors that private equity firm Veritas is considering a takeover of the company. |
Syneos Health (SYNH) to Go Private, Reports Q2 PerformanceSyneos Health (SYNH) announces shareholders' approval for the impending merger and releases second-quarter 2023 financial results. |
Syneos Health Stockholders Approve Agreement with Private Investment ConsortiumMORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced that the Company’s stockholders approved an agreement to take the Company private through an acquisition by a consortium of private investment firm affiliates comprised of Elliott Investment Management L.P., Patient Square Capital, and Veritas Capital at a special meeting of stockholders he |
Companies Weigh Growing Power of Cloud Providers Amid AI BoomA wave of partnerships between AI model makers and cloud providers is leading tech chiefs to assess the benefits of convenience versus becoming too reliant on any one vendor. |